EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
91 hedge funds and large institutions have $291M invested in Eiger BioPharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-11
Holders Change %
-10.78%
% of All Funds
1.61%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
13
Increased
42
Reduced
19
Closed
24
Calls
$4.16M
Puts
$2.28M
Net Calls
+$1.88M
Net Calls Change
+$2.82M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$48.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$19.5M |
| 3 |
LCM
Laurion Capital Management
New York
|
$3.1M |
| 4 |
Millennium Management
New York
|
$1.89M |
| 5 |
BlackRock
New York
|
$29.2M |
